{"id":"NCT00553787","sponsor":"VIVUS LLC","briefTitle":"Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions","officialTitle":"A Phase III Randomized, Double-Blind, Placebo Controlled Multicenter Study to Determine the Safety and Efficacy of VI-0521 in the Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2009-06","completion":"2009-06","firstPosted":"2007-11-06","resultsPosted":"2012-09-06","lastUpdate":"2012-09-10"},"enrollment":2487,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Obesity","Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"VI-0521","otherNames":[]},{"type":"DRUG","name":"VI-0521","otherNames":[]},{"type":"DRUG","name":"VI-0521","otherNames":[]}],"arms":[{"label":"VI-0521 Top","type":"EXPERIMENTAL"},{"label":"VI-0521 Mid","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of VI0521 compared to placebo in treatment of obesity in an adult population with obesity related co-morbid conditions.","primaryOutcome":{"measure":"Percent Weight Loss From Baseline to Week 56","timeFrame":"Baseline to 56 weeks","effectByArm":[{"arm":"Placebo","deltaMin":1.24,"sd":0.277},{"arm":"VI-0521 Mid","deltaMin":7.81,"sd":0.365},{"arm":"VI-0521 Top","deltaMin":9.84,"sd":0.275}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":19},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["28455281","25249652","21481449"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":40,"n":993},"commonTop":["Upper Respiratory Tract Infection","constipation","dry mouth","paresthesia","Nasopharyngitis"]}}